JAK2 and myeloproliferative neoplasm: In particular, the latter group had higher probabilities of having splenomegaly, MPN-like megakaryocytes in the residual marrow, a higher mean JAK2 V617F-variant allele frequency at diagnosis, a complex karyotype, and the morphologic resurgence of MPN after from induction chemotherapy.